rs5913
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP7BA1BP4
This summary comes from the ClinGen Evidence Repository: The c.2916G>A; p.Pro972= synonymous variant has not been reported in the literature to our knowledge. It is present in a non-Finnish European control population at an allele frequency of 0.005351 and no splice impact is predicted. In summary, this variant meets criteria to be classified as benign for GT. GT-specific criteria applied: BA1, BP4, and BP7. LINK:https://erepo.genome.network/evrepo/ui/classification/CA8602530/MONDO:0010119/011
Frequency
Consequence
NM_000419.5 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITGA2B | NM_000419.5 | c.2916G>A | p.Pro972= | synonymous_variant | 28/30 | ENST00000262407.6 | NP_000410.2 | |
ITGA2B | XM_011524750.2 | c.3069G>A | p.Pro1023= | synonymous_variant | 28/29 | XP_011523052.2 | ||
ITGA2B | XM_011524749.2 | c.2995-216G>A | intron_variant | XP_011523051.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITGA2B | ENST00000262407.6 | c.2916G>A | p.Pro972= | synonymous_variant | 28/30 | 1 | NM_000419.5 | ENSP00000262407 | P1 | |
ITGA2B | ENST00000648408.1 | c.2349G>A | p.Pro783= | synonymous_variant | 24/25 | ENSP00000498119 | ||||
ITGA2B | ENST00000587295.5 | c.253+1147G>A | intron_variant | 3 | ENSP00000467269 | |||||
ITGA2B | ENST00000592462.5 | n.2427G>A | non_coding_transcript_exon_variant | 15/15 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00338 AC: 514AN: 152080Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.00291 AC: 729AN: 250896Hom.: 4 AF XY: 0.00305 AC XY: 414AN XY: 135702
GnomAD4 exome AF: 0.00470 AC: 6863AN: 1461676Hom.: 22 Cov.: 31 AF XY: 0.00459 AC XY: 3339AN XY: 727142
GnomAD4 genome AF: 0.00338 AC: 514AN: 152198Hom.: 4 Cov.: 32 AF XY: 0.00285 AC XY: 212AN XY: 74400
ClinVar
Submissions by phenotype
Glanzmann thrombasthenia Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Benign, reviewed by expert panel | curation | ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen | May 07, 2021 | The c.2916G>A; p.Pro972= synonymous variant has not been reported in the literature to our knowledge. It is present in a non-Finnish European control population at an allele frequency of 0.005351 and no splice impact is predicted. In summary, this variant meets criteria to be classified as benign for GT. GT-specific criteria applied: BA1, BP4, and BP7. - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | ITGA2B: BP4, BP7, BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 07, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at